I agree, should have told market before SPP. Poor from directors. Only delaying the timing, profit should be up following financial year.Leighton would have to think about a T/O.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025